PMA device
GORE EXCLUDER AAA Endoprosthesis product family
W. L. Gore & Associates, Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment (MIH, Class III) · First FDA decision Nov 5, 2008, newest Aug 2, 2021Aortic aneurysm and dissection
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
9
PMA pathway
Device trials
10
Naming "GORE EXCLUDER AAA"
MAUDE reports
700
Brand "GORE EXCLUDER AAA", since 2015
PubMed studies
12
Mentioning "GORE EXCLUDER AAA"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing GORE EXCLUDER AAA Endoprosthesis product family
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 9 decisions filed under this name.
- GORE EXCLUDER AAA Endoprosthesis product familyPMA supplement
P020004-S179 · Decided Aug 2, 2021 · 164 days after receipt · Normal 180 Day Track No User Fee
Device type: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT (MIH) · Cardiology
- GORE EXCLUDER AAA EndoprosthesisPMA supplement
P020004-S166 · Decided Feb 5, 2020 · 180 days after receipt · Normal 180 Day Track
Device type: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT (MIH) · Cardiology
P020004-S137 · Decided Mar 6, 2017 · 216 days after receipt · Normal 180 Day Track No User Fee
Device type: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT (MIH) · Cardiology
3 more FDA decisions with a free account
Older decisions: P020004-S040, P020004-S039, P020004-S035
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Application of Skin Substitute Grafts for Treatment of DFU and VLU of Lower ExtremitiesLocal determinationIn effectL36377First Coast Service Options, Inc.Updated Nov 21, 2019
Clinical trials
Device studies on ClinicalTrials.gov that name "GORE EXCLUDER AAA", any status and sponsor, newest update first.
- Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic AneurysmsActive, not recruiting
W.L.Gore & AssociatesNot on our public-company list
NCT03728985 · 102 participants · Start Jun 17, 2019 · Primary completion Jan 4, 2023
Device: GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis · For: Thoracoabdominal Aortic Aneurysm
Sites: Birmingham, Alabama; Scottsdale, Arizona; Los Angeles, California · 44 sites in all
- GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Approval StudyActive, not recruiting
W.L.Gore & AssociatesNot on our public-company list
NCT06578741 · 310 participants · Start Nov 25, 2024 · Primary completion Jun 25, 2027
Device: GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE Device) · For: Abdominal Aortic Aneurysm; Pararenal Aortic Aneurysm; Thoracoabdominal Aortic Aneurysm
Sites: Stanford, California
- Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE TrialPivotal-lookingRecruiting
Medtronic CardiovascularPublic (MDT)
NCT05378347 · 600 participants (planned) · Start Jan 5, 2023 · Primary completion May 2027
Device: Medtronic Endurant II or Endurant IIs Stent Graft System; Gore Excluder or Gore/ Excluder Conformable AAA Endoprosthesis · For: Abdominal Aortic Aneurysm; Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder); Abdominal Aortic Aneurysm >= 5.0 Centimeters in Female (Disorder)
Sites: Loma Linda, California; Newport Beach, California; Orange, California · 68 sites in all
7 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "GORE EXCLUDER AAA", and for the whole product code for context.
This brand
700 reports: 41 malfunction, 630 injury, 27 death
Whole product code MIH
43,674 reports: 7,807 malfunction, 32,331 injury, 3,518 death
Newest reports for this brand
MW5167493 · Received Mar 11, 2025 · Event dated Feb 24, 2025
Device type: System, Endovascular Graft, Aortic Aneurysm Treatment (MIH)
Patient problem as coded: Obstruction/Occlusion
19237323 · Received May 3, 2024 · Event dated Apr 9, 2024
Device type: System, Endovascular Graft, Aortic Aneurysm Treatment (MIH)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Aneurysm; Vascular Dissection
- GORE EXCLUDER AAA ENDOPROSTHESISMalfunction
19213365 · Received Apr 30, 2024 · Event dated Dec 29, 2023
Device type: System, Endovascular Graft, Aortic Aneurysm Treatment (MIH)
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- GORE EXCLUDER AAA EndoprosthesisTerminated
Z-0995-2020 · Started Jan 6, 2020
Reason given: Firm has received reports of leading end catheter component separations.
Cause as FDA categorized it: Employee error · Device type: System, Endovascular Graft, Aortic Aneurysm Treatment (MIH)
Z-0996-2020 · Started Jan 6, 2020
Reason given: Firm has received reports of leading end catheter component separations.
Cause as FDA categorized it: Employee error · Device type: System, Endovascular Graft, Aortic Aneurysm Treatment (MIH)
Published research
The most relevant PubMed records for "GORE EXCLUDER AAA"[tiab]. The summary above synthesizes these.
- The Gore Excluder AAA endoprosthesis with C3 delivery system: results in high-volume centers.
Krajcer Z · J Cardiovasc Surg (Torino) · 2014Review
- Long Term Real World Performance of the Gore Excluder AAA Endoprosthesis Featuring the C3 Delivery System: Ten Year Results from the European C3 Module of the GREAT Registry.
Bischoff MS, Verhoeven E, Katsargyris A, et al. · Eur J Vasc Endovasc Surg · 2026Multicenter Study, Observational Study
- Long-Term Outcome of the GORE EXCLUDER AAA Endoprosthesis for Treatment of Infrarenal Aortic Aneurysms.
Poublon CG, Holewijn S, van Sterkenburg SMM, et al. · J Vasc Interv Radiol · 2017
- Improved effectiveness of the repositionable GORE EXCLUDER AAA endoprosthesis featuring the C3 delivery system compared with the original GORE EXCLUDER AAA endoprosthesis for within the instructions for use treatment of aortoiliac aneurysms.
Tsolakis IA, Kakkos SK, Papageorgopoulou CP, et al. · J Vasc Surg · 2019Comparative Study
- Endovascular Repair for Ruptured Axillary Artery Aneurysm Proximal to Hemodialysis Access.
Takigawa T, Tokunaga S, Baba H, et al. · Vasc Endovascular Surg · 2019Case Reports
- Incidence, predictors, and prognostic impact of in-hospital serious adverse events in patients ࣙ75 years of age undergoing elective endovascular aneurysm repair.
D'Oria M, Trimarchi S, Lomazzi C, et al. · Surgery · 2023
- Intraoperative position system guided with augmented reality improves the learning curve of endovascular navigation in endovascular-naïve operators.
Wong J, Mesnard T, Vacirca A, et al. · J Vasc Surg · 2025Comparative Study
- Outcomes of the Gore Excluder abdominal aortic aneurysm leg endoprosthesis for treatment of central vein stenosis or occlusion in patients with chronic hemodialysis.
Chen YY, Wu CK, Lin CH · J Vasc Surg Venous Lymphat Disord · 2020
- Endovascular treatment of a blunt aortic injury in Iraq: extension of innovative endovascular capabilities to the modern battlefield.
Propper BW, Alley JB, Gifford SM, et al. · Ann Vasc Surg · 2009Case Reports
- Excluder Stent Graft-Related Outcomes in Patients with Aortic Neck Anatomy Outside of Instructions For Use (IFU) within the Global Registry for Endovascular Aortic Treatment (GREAT): Mid-term Follow-Up Results.
Barry IP, Barns M, Verhoeven E, et al. · Ann Vasc Surg · 2021Multicenter Study
- Inflammatory Aneurysm of the Common Iliac Artery With Elevated Serum Levels of Immunoglobulin G4 Manifesting After Endovascular Aneurysm Repair: A Case Report.
Ishikawa N, Yamamoto N, Unno N, et al. · Cureus · 2025Case Reports
- Early outcome of endovascular aneurysm repair in challenging aortic neck morphology based on experience from the GREAT C3 registry.
Bachoo P, Verhoeven EL, Larzon T · J Cardiovasc Surg (Torino) · 2013Multicenter Study
Other devices of this type
Also filed under product code MIH.
- GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1W. L. Gore & Associates, Inc. · PMA 2026
- Ancure Endograft SystemBoston Scientific Corp · PMA 2003
- Aneurx Stent Graft SystemMedtronic Vascular · PMA 2011
- Talent Thoracic Stent Graft SystemMedtronic Vascular · PMA 2016
- Talent Abdominal Stent Graft SystemMedtronic Vascular · PMA 2014
- TREO® Abdominal Stent-Graft SystemBolton Medical, Inc. · PMA 2026
- Zenith Fenestrated AAA Endovascular GraftCook, Inc. · PMA 2022
- Powerlink System with Intuitrak Delivery SystemEndologix, LLC · PMA 2013
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.